• Explore /
  • Poster
  • / Phase 1 of ABTL0812, a proautophagic drug, in combination with paclitaxel and carboplatin at first-line in advanced endometrial cancer and squamous cell lung carcinoma.

Phase 1 of ABTL0812, a proautophagic drug, in combination with paclitaxel and carboplatin at first-line in advanced endometrial cancer and squamous cell lung carcinoma.

Abstract Poster

Authors

null

Lorena Farinas-Madrid

Vall d’Hebron University Hospital Institute of Oncology (VHIO), Barcelona, Spain

Lorena Farinas-Madrid , Purificación Estévez-García , Jose Alejandro Perez-Fidalgo , Joaquim Bosch-Barrera , Teresa Moran , Ernest Nadal , Victor Rodriguez Freixinos , Elisa Calvo , Alejandro Falcon , Paloma Martín-Martorell , Marisol Huerta Alvaro , Maria Pilar Barretina-Ginesta , Margarita Romeo , Marta Gil-Martin , Elena Garralda , Jordi Rodon , Jose M. Lizcano , Carles Domenech , Jose Alberto Alfon , Ana Oaknin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics and Tumor Biology (Nonimmuno)

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

New Targets and New Technologies (non-IO)

Clinical Trial Registration Number

NCT03366480

Citation

J Clin Oncol 37, 2019 (suppl; abstr 3089)

DOI

10.1200/JCO.2019.37.15_suppl.3089

Abstract #

3089

Poster Bd #

81

Abstract Disclosures

Similar Posters

First Author: Joaquim Bosch-Barrera

First Author: Christian Marth

First Author: Shannon Neville Westin

First Author: Mario Javier Pineda